Australia TGA ARTG recordBlastGen - In vitro fertilization culture medium
Australia TGA ARTG Registered Device · Origio Australasia Pty Ltd · Origio A/S · Class III · Started January 23, 2023
Good Name: Origio Australasia Pty Ltd - BlastGen - In vitro fertilization culture medium
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- January 23, 2023
- Effective Date
- January 23, 2023
- Name
- Origio A/S
- Country
- Denmark
- Address
- Knardrupvej 2, Malov, DK-2760
BlastGen is for the culture of 4-8 cell stage human embryos to the blastocyst stage. BlastGen may also be used for embryo transfer.
Access comprehensive regulatory information for BlastGen - In vitro fertilization culture medium in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Origio Australasia Pty Ltd, manufactured by Origio A/S in Denmark. The device registration started on January 23, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.